G. Auffarth Germany

Introducing LuxSmart™: The new EDOF preloaded IOL for presbyopia

P. Stodulka Czech Republic

First clinical outcomes with the LuxSmart™ IOL

R. Ang Philippines

Innovating refractive practice with Transepi PRK and Supracor™ Strong

F. Arnalich Spain

New transforming therapeutic techniques with the VICTUS® femtosecond laser platform

J. Hjortdal Denmark

Welcome

B. Cochener-Lamard France

Review of ESCRS clinical trends survey data

J. Guell Spain

The Impact of OSD on surgical results: Cases in point

B. Cochener-Lamard France

Integrating efficient and effective screening for dry eye into the preoperative cataract exam

J. Hjortdal Denmark

Identifying and meeting ocular surface treatment goals before surgery

ALL

Panel discussion

J. Hjortdal Denmark

Conclusions

R. Nuijts The Netherlands

Introduction

M. Labetoulle France

Making the patient journey efficient

B. Cochener-Lamard France

Peri‐operative pathways: Re‐engineering care to achieve the ‘triple aim’

R. Mencucci Italy

The pursuit of happiness in the cataract patient

R. Nuijts The Netherlands

Conclusion

Q&A Session

K. G. Gundersen Norway

Introducing AcrySof® Vivity® clinical data overview

M. Lawless Australia

The evolution of presbyopia correction technology. What is X wave technology?

F. Carones Italy

Acrysof® IQ Panoptix® and Acrysof® IQ Vivity® . The right IOL for the right patient

M. Guarro Spain

Early experience with Acrysof® IQ Vivity®

E. Ligabue Italy

Early experience with Acrysof® IQ Vivity®

Welcome and ARS questions

R. Nuijts The Netherlands

Review of ESCRS presbyopia clinical survey data

G. Auffarth Germany

Maximizing visual quality at all distances

B. Dick Germany

Maximizing visual performance while minimizing dysphotopsia

ALL

Panel Discussion: Matching presbyopia patient needs to new IOL design categories

B. Cochener-Lamard France

Best practices for patient screening and preoperative measurements

F. Ribeiro Portugal

Pearls on intraoperative surgical alignment

O. Findl Austria

Managing the unhappy postop presbyopia IOL patient

ALL

Final ARS

C. Holmes UK

Welcome lecture: Allergan/AbbVie commitment to ophthalmology

J. Crowston Singapore

Limitations of current glaucoma therapy

H. Reitsamer Austria

Changing dimensions in minimally invasive filtration surgery

J. Crowston Singapore, H. Reitsamer Austria

Discussion & Q&A Session

J. Crowston Singapore, H. Reitsamer Austria

Wrap Up & Close

K. Dziekan Switzerland

Welcome and Introduction

D. Tognetto Italy

CENTURION® Vision System with ACTIVE SENTRY: increased safety and confidence to enable the efficiency you want

R. Rejdak Poland

NGENUITY® 3D Visualisation System in cataract surgery

L. Castillón Spain

Efficiency gain through SMART Pathways

ALL

Live Q&A

J.F. Pérez Spain

Short introduction; “cutting edge” for presbyopia correction IOLs

G. Cervantes-Coste Mexico

When to operate our patients with intraocular surgery to maximize the efficacy and safety results?

J.F. Pérez Spain

How to reduce dysphotopsies without losing near focus?

S. Srinivasan UK

What are the “Red Lines” for implanting Multifocal IOLs?

B. Harrisberg Australia

Is reversibility possible with Multifocal IOLs

F. Ribeiro Portugal

Welcome & Introduction

F. Ribeiro Portugal

The ESCRS position statement on intermediate vision

T. Röck, U. Schiefer, J. Ungewiss Germany

Enhanced intermediate vision – beneficial impact on car driving

F. Carones Italy

Next generation PCIOL – performance under all conditions

F. Kerkhoff The Netherlands

Q&A on first experience with new IOL technology

F. Ribeiro Portugal

IOL fulfilling different patient demands

ALL

Discussion

G. Schmidinger Austria

Femto assisted DALK surgery – study results

J. Mehta Singapore

Liquid transplant

S-P. Chee Singapore

Handling complex cataract cases with Z8

R. Menapace Austria

Low energy and its effect on the macula

L. Izquierdo, A. Chayet, T. Seiler, J. Mehta

Panel Discussion about the new Lenticule extraction: CLEAR

M. Rolando Italy

Welcome and open

E. Messmer Germany

Burden of dry eye disease

J. Katz USA

Breaking the cycle of artificial tear use

M. Labetoulle France

The impact of eye surgery on ocular surface disease

ALL

Panel Discussion and Q&A

M. Rolando Italy

Summary and close

A. Cummings Ireland

Welcome and audience response questions

T. Kohnen Germany

Reviewing trends from ESCRS delegate surveys

A. Cummings Ireland

Key sustained practice improvements implemented in today’s new normal

F. Carones Italy

Effective patient conversations

D. Breyer Germany

Educating patients regarding Refractive IOLs in today’s new normal

ALL

Patient conversations: case studies

ALL

Panel discussion

F. Carones Italy

Key takeaway messages and final ARS questions

D. Breyer Germany

My experience with glistening-free Optiflex Trio IOLs

Sri Ganesh India

My 2 years clinical experience with Eyecryl Phakic IOLs & Visian Toric ICLs

M. Busin Italy

Eyecryl toric IOLs for correcting corneal astigmatism after keratoplasty

A. Agca Turkey

Eyecryl phakic IOLs: 4 years clinical study results

T. Kohnen Germany

Welcome & Introduction

D. Koch USA

Identifying possible complexities preoperatively: from cornea to retina

ALL

Panel Discussion

O. Findl Austria

Streamline the patient workflow – how to benefit from remote surgical planning

ALL

Panel Discussion

G. Roper USA

Intraoperative tools & techniques to simplify complex cataract cases

ALL

Panel Discussion

A. Borkenstein Austria

Surgical experience in challenging cases of pseudoexfoliation syndrome

ALL

Panel Discussion

M. Latina USA

Selective Laser Trabeculoplasty: A clinically proven first-line treatment

P. Gouws UK

A new treatment option for glaucoma

N. Benhatchi France

Subcyclo treatment settings? Why duty cycle should be tuned on a case-by-case basis?

Y. Lachkar France

Conclusion